cas 13544-44-0|| where to buy 2,4-dichloro-5-iodopyrimidine

Nom du produit:2,4-dichloro-5-iodopyrimidine

IUPAC Name:2,4-dichloro-5-iodopyrimidine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM112286-100g	in stock	ľȃĲ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 13544-44-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:13544-44-0; Formule moléculaire:C4HCl2IN2; Point de fusion:-; Code SMILES:IC1=CN=C(Cl)N=C1Cl; Densité:

: Numéro de catalogue:CM112286; Poids moléculaire:274.87; Point d'ébullition:; N° Mdl:MFCD01898087; Stockage:

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: INX-315; Incyclix Bio announces FDA clearance of investigational new drug application for INX-315 in patients with advanced or metastatic cancer. INX-315 is a novel, potent and selective inhibitor of Cyclin-dependent kinase 2 (CDK2) with compelling pre-clinical efficacy and safety data.
CDK2 is thought to play an important role in driving proliferation of certain cancers, including those harboring CCNE1 amplification and breast cancers that have acquired resistance to CDK4/6 inhibitors (CDK4/6i).